ADA Scientific Sessions 2025 Abstract

Oral Small Molecule GLP-1 Receptor Agonist Demonstrates Beneficial Effects in Parkinson's Disease–Like Model Using Humanized GLP-1R Mice

By Ziyi Wang, Ting Mao, Xiankang Fang, Fang Zhang

Experiments in animalsInterventions

The paper

Ziyi Wang, Ting Mao, Xiankang Fang, Fang Zhang

Shanghai

ADA Scientific Sessions 2025 Abstract, 13 Jun 2025

Presented at ADA Scientific Sessions 2025, late-breaking 1985-LB

doi.org/10.2337/db25-1985-lb

Neurology Genetics4 Oct 2026
GLP-1 receptor agonists link to lower stroke and Alzheimer risk
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial